Jeffrey S. Hochman

Jeffrey is a member of the Business Law Section of the American Bar Association. He has spoken on the Sarbanes-Oxley Act and corporate governance issues, MD&A, negotiating merger agreements and other corporate and securities issues for the Practising Law Institute.

Recent significant transactions include representing:

• iA Financial Corporation in its acquisition of Vericity
• The underwriters in Marsh & McLennan’s $1.6 billion senior notes offering, $1 billion senior notes offering, $5 billion multi-tranche debt offering, two $750 million and $600 million senior notes offerings, and €1.1 billion and $250 million senior notes offerings
• Frosch Travel Group in its sale to JPMorgan Chase & Co.
• Veritas Energy and Carnelian Energy Capital Management in the sale of Permian Basin assets to Northern Oil and Gas for $406.5 million
• The underwriters in connection with James River Group Holding’s public offering of the company’s common shares, valued at $201,422,500
• Samson Resources II, LLC in the $215 million sale of its Powder River Basin Assets
• Insight Partners affiliates as selling stockholders in nCino’s $555 million secondary public offering of common stock (NASDAQ: NCNO)
  
• Global Emerging Markets Group in connection with its $200 million share subscription facility with Surf Global Air Ltd.
• Insight Partners in its $294 million secondary offering of 9.2 million shares of common stock of Tenable Holdings (NASDAQ: TENB)
• HealthEquity (HQY) in its initial public offering and several follow-on offerings, as well as the offerings under Rule 144A of $600 million of its senior notes due 2029.
• The selling stockholders in their approximately $117 million sale of 8,000,000 shares of Class A common stock and approximately $100 million subsequent sale of 8,700,000 shares of Class A common stock of Liberty Oilfield Services Inc.
  
• The underwriters in Marsh & McLennan’s $5 billion multi-tranche debt offering, and two $750 million, €1.1 billion, $600 million and $250 million senior notes offerings
  
• W. R. Berkley Corporation in connection with various public offerings of common stock, senior notes, hybrid bonds and trust preferred securities, including its recent $400 million, $300 million and $170 million offerings of senior notes, two $300 million offerings of subordinated debentures, $175 million offering of subordinated debentures, $290 million offering of subordinated debentures, $110 million offering of subordinated debentures, $350 million offering of senior notes and $350 million offering of subordinated debentures
• The underwriters in Marsh & McLennan’s $5 billion multi-tranche debt offering and prior $600 million offering of senior notes
• Issuer Liberty Oilfield Services and selling shareholder R/C Energy IV Direct Partnership in Liberty’s initial public offering
• Teva Pharmaceutical Industries Ltd. in its series of three multi-tranche, multi-market offerings of senior notes aggregating $20.4 billion to finance its pending acquisition of Actavis Generics, the worldwide generic pharmaceutical business of Allergan plc
• Teva Pharmaceutical in its $6.75 billion aggregate stock offerings supporting its pending acquisition of Actavis Generics
• Special Committee of the Board of Directors of WuXi PharmaTech Inc. in its $3.3 billion management-led leveraged buyout
• Teva Pharmaceutical Industries Ltd. in its €2 billion multi-tranche Eurobond offering
• Teva Pharmaceutical Industries Ltd. in its $1.3 billion debt tender offer for five series of senior notes
• New Breed Holding Company in its $615 million acquisition by XPO Logistics, Inc.
• Peter J. Solomon Company as financial adviser to R.G. Barry Corporation in R.G. Barry’s acquisition by Mill Road Capital
• Teva Pharmaceutical Industries Limited in its $2 billion offering of senior notes
• Doublemousse B.V. and Moussetrap as the selling stockholders in the $588 million secondary offering of Ulta Beauty common stock
• Teva Pharmaceutical Industries Limited in its debut €1 billion and CHF 450 million Regulation S offerings of senior notes
• AboveNet Inc.’s Board of Directors in connection with AboveNet’s approximately $2.2 billion agreement to be acquired by Zayo Group LLC
• Teva Pharmaceutical Industries Limited in its $5 billion offering of senior notes – the largest securities offering by an Israeli company
• Allied World Assurance Company Holdings, AG in connection with Transatlantic Holdings, Inc.
• The special committee of M&F Worldwide Corp. in connection with its $483 million merger agreement with MacAndrews & Forbes Holdings Inc.
• Teva Pharmaceutical Industries Limited in its consumer health care joint venture with The Procter & Gamble Company
• Teva Pharmaceutical Industries Limited in its $750 million offering of senior notes
• Teva Pharmaceutical Industries Limited in its $2.5 billion offering of senior notes
• The underwriters in PartnerRe Ltd’s $500 million offering of senior notes
• RenaisanceRe Holdings Ltd. in its investment in Essent Group Ltd., the first private mortgage insurance company in the United States since the start of the current financial crisis
• RenaisanceRe Holdings Ltd. in the creation of a Timicuan Reinsurance II Ltd., a new Bermuda reinsurance “sidecar” company established to provide additional reinsurance capacity for the Florida homeowners market
• The underwriters in The Allstate Corporation’s $1 billion offering of senior notes
• Teva Pharmaceutical Industries Limited in connection with its $8.9 billion acquisition of Barr Pharmaceuticals, Inc.
• Lev Pharmaceuticals, Inc. in connection with its $617.5 million acquisition by ViroPharma Incorporated for a combination of cash, stock and contingent value rights
• Teva Pharmaceutical Industries Limited in connection with its approximately $360 million acquisition of  Bentley Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Limited in connection with its $400 million acquisition of CoGenesys, Inc.
• Allied World Assurance Company Holdings, Ltd in its $563.4 million share repurchase from a founding shareholder
• The underwriters in connection with The Allstate Corporation’s $1 billion hybrid offering of subordinated debentures
• Marsh Inc. in connection with the creation of MaRI (Marsh Risk Innovations), a first-of-its-kind insurance facility designed to provide additional capacity to the depleted property catastrophe insurance market
• Teva Pharmaceutical Industries Limited in connection with its $9.9 billion acquisition of Ivax Corporation and its $3.4 billion acquisition of Sicor Inc
• Teva Pharmaceutical Industries Limited in connection with various registered and Rule 144A convertible debt offerings in excess of $5 billion
• The underwriters in connection with various debt and hybrid securities offerings by The Allstate Corporation and PartnerRe Ltd. aggregating approximately $4.5 billion
• Strayer Education, Inc. in connection with public offerings of its common stock
• Numerous private equity investments and acquisitions for Warburg Pincus & Co. and its portfolio companies
• RenaissanceRe Holdings Ltd. in connection with various joint ventures and “sidecar” transactions
• Special Committee of Juniper Financial in connection with a proposed financing from its controlling shareholder and the Special Committee of Hartford Life in connection with its $1.1 billion “going private” transaction
• Peter J. Solomon Company in its capacity as financial adviser to Lands’ End in connection with its $1.9 billion sale to Sears
• MidAmerican Energy in its $9 billion “going private” merger